Ipratropium Bromide-Mediated Myocardial Injury in In Vitro Models of Myocardial Ischaemia/Reperfusion

Ipratropium bromide-mediated myocardial injury in in vitro models of myocardial ischaemia/reperfusion.

Ipratropium bromide, a nonselective muscarinic antagonist, is widely prescribed for the treatment of chronic obstructive pulmonary disease (COPD). Analyses of COPD patients, with underlying ischaemic heart disease, receiving anticholinergics, have indicated increased risk of severity and occurrence of cardiovascular events (including myocardial infarction). The present study explored whether ip...

W7: In Vitro Traumatic Brain Injury Models

لطفاً به چکیده انگلیسی مراجعه شود.

Ineffectiveness of ipratropium bromide in acute bronchiolitis.

In a double blind randomised trial, we found no evidence that nebulised ipratropium bromide was of clinical benefit in acute bronchiolitis.

Ipratropium bromide bronchodilator solution.

ESTIMATION OF POTASSIUM, CALCIUM, AND MAGNESIUM IN BLOOD AND MYOCARDIAL TISSUE, AND DIAGNOSTIC IMPORTANCE OF URINARY MAGNESIUM EXCRETION IN EXPERIMENTALLY-INDUCED MYOCARDIAL INJURY

The results obtained in the present investigations point to a definite correlation between the onset of myocardial injury, electrocardiographic changes and biochemical changes. Changes in the electrocardiogram and elevated serum levels were paralleled by an increased excretion of magnesium in urine as early as one hour. Serum calcium and serum potassium levels did not show any significant ...